Oral administration activity determination of recombinant osteoprotegerin from silkworm larvae

Molecular Biotechnology

Volumn 35, Issue 2, 2007, Pages 179-184

  Xiao, Hai Long ^a   Zhang, Yao Zhou ^b   Wu, Xiang Fu ^c  

^a Hangzhou Institute of Calibration and Testing for Quality and Technical Supervision   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Bioactivity; Oral administration; Osteoprotegerin; Silkworm larvae

Indexed keywords

BIOACTIVITY; BIOTECHNOLOGY; BONE; CALCIUM; CONCENTRATION (PROCESS);

CALCIUM CONCENTRATION; ORAL ADMINISTRATION; OSTEOPROTEGERIN; SILKWORM LARVAE;

PROTEINS;

CALCIUM; ESTROGEN; OSTEOPROTEGERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; SILKWORM;

BOMBYX MORI; MUS;

ADMINISTRATION, ORAL; ANIMALS; BIOTECHNOLOGY; BOMBYX; BONE REMODELING; CALCIUM; FEMALE; HUMANS; LARVA; MALE; MICE; MICE, INBRED ICR; OSTEOPROTEGERIN; OVARIECTOMY; RECOMBINANT PROTEINS;

EID: 34247340934     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686103     Document Type: Article

References (18)

1. Kong, Y.-Y. and Penninger, J. M. (2000) Molecular control of bone remodeling and osteoporosis. Exper. Gerontol. 35, 947-956.
2. Vaananen, H. K. and Harkonen, P. L. (1996) Estrogen and bone metabolism. Maturitas 23, S65-S69.
3. Tsuda, E., Goto, M., Mochizuki, S., et al. (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234,137-142.
4. Simonet, W. S., Lacey, D. L., Dunstan, C. R., et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319.
5. Yamaguchi, K., Kinosaki, M., Goto, M., et al. (1998) Characterization of structural domains of human osteoclastogenesis inhibitory factor. J. Biol. Chem. 273, 5117-5123.
6. Yasuda, H., Shima, N., Nakagawa, N., et al. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329-1337.
7. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev. 20, 345-357.
8. Yamamoto, M., Murakami, T., Nishikawa, M., et al. (1998) Hypocalemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. Endocrinology 139, 4012-4015.
9. Akatsu, T., Murakami, T., Ono, K., et al. (1998) Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. Bone 23, 495-498.
10. Wittrant, Y., Theoleyre, S., Chipoy, C., et al. (2004) RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim. Biophys. Acta 1704, 49-57.
11. Liu, J. Z., Hu, Y. Y., Ji, Z. L., and Chen, S. M. (2003) Expression of human osteoprogeterin gene in E.coli and bioactivity analysis of expression product. Chin. J. Surg. 41, 641-645.
12. Lü H. S. (1998) Molecular biology of insect viruses. Beijing: China Agricultural Scientech Press, pp. 547-580.
13. Xiao, H. L., Jin, Y. F., and Zhang, Y. Z. (2004) Expression and identification of mutated osteoprotegerin in culture cells and larvae of silkworm. Acta Biochimica et Biophysica Sinica 36, 331-335.
14. Liu, Z., Yang, G. Z., and Wu, X. F. (2004) Production of recombinant human osteoprotegrin from Trichoplusia ni cells and Bombyx mori larvae. Protein and Peptide Letters 11, 317-323.
15. Qian, D. M., Shen, G. Q., and Ke, R. L. (1994) Biological assay of calcitonin by blood calcium determination in rats. Chin. J. Pharma. Anal. 14, 30-34.
16. He, Z. Y., Yang, G. Z., and Chen, Z. Y. (2000) A novel isoform of osteoprotegerin gene: cloning and expression and its hypocalcemic effect in mice. Protein and Peptide Letters 7, 233-240.
17. Jin, Y. F. and Zhang, Y. Z. (2004) Silkworm functional proteomics related with absorption of oral administration of protein drug. Acta Biochimica et Biophysica Sinica 36, 71.
18. Schmidt, F. R. (2004) Recombinant expression system in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 65, 363-372.